Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Jun 27, 2025; 17(6): 104545
Published online Jun 27, 2025. doi: 10.4240/wjgs.v17.i6.104545
Table 3 Misjudgment rate of predicting the efficacy of neoadjuvant chemotherapy for gastric cancer using different texture feature selection and classification analysis methods in computed tomography images
Discrimination methods
RDA misclassification rate (%)
PCA misclassification rate (%)
LDA misclassification rate (%)
NDA misclassification rate (%)
Venous phase
Fisher21.8618.4514.9211.53
POE + ACC19.7516.8213.459.86
MI18.3215.4611.858.92
FPN17.5314.2510.637.85
Arterial phase
Fisher25.9222.8519.4616.85
POE + ACC24.5321.4618.2515.42
MI22.8519.7516.9214.53
FPN21.4618.5315.8613.92